| Name | Olopatadine |
|---|---|
| Synonyms |
Olopatadine(W.S)
OlopatadineQ: What is Olopatadine Q: What is the CAS Number of Olopatadine Q: What is the storage condition of Olopatadine (Z)-2-(11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxin-2-yl)acetic acid Olopatadine HCl API Olopatadine & Olopatadine Hydrochloride Olopatadine //BP a-Hydroxy-Olopatadine Olopatatadine {(11E)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid OLOPATADINE 2-Methyl-99-nitrobenzyl&chloride {(11Z)-11-[3-(diMethylaMino)propylidene]-6,11- dihydrodibenzo[b,e]oxin-2-yl}acetic acid Dibenz[b,e]oxin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, (11Z) Olopatadine 13CD3 6,11-dihydrodibenzo[b,e]oxin-2-yl) MFCD00865645 11-((z)-3-(dimethyl-amino)propylidene)-6,11-dihydrodibenz[b,e]oxin-2-acetic acid 2-[(11E)-11-[3-(dimethylamino)propylidene]-6H-benzo[c]benzoxin-2-yl]acetic acid 2-(11-(3-(Dimethylamino) propylidene) Olopatadine Impurity E KW 4679 |
| Description | Olopatadine is an orally active and selective histamine 1 (H1) receptor antagonist and a mast cell stabilizer. Olopatadine prevents immunologically stimulated pro-inflammatory mediator release from human conjunctival mast cells. Olopatadine can be used for researching allergic conjunctivitis[1][2]. |
|---|---|
| Related Catalog | |
| Target |
H1 Receptor |
| In Vitro | Olopatadine inhibits anti-IgE antibody-mediated release of TNF-α from human conjunctival mast cells, and significantly decreases the mast cell supernatant-mediated upregulation of ICAM (intercellular adhesion molecule)-1 on human conjunctival epithelial cells in vitro[2]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 523.0±50.0 °C at 760 mmHg |
| Molecular Formula | C21H23NO3 |
| Molecular Weight | 337.412 |
| Flash Point | 270.1±30.1 °C |
| Exact Mass | 337.167786 |
| PSA | 49.77000 |
| LogP | 3.14 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.641 |
|
~89%
113806-05-6 |
| Literature: WO2006/10459 A1, ; Page/Page column 14-15 ; |
|
~45%
113806-05-6 |
| Literature: WO2010/89268 A2, ; Page/Page column 13-14 ; |
|
~99%
113806-05-6 |
| Literature: US2007/232814 A1, ; Page/Page column 25; 26 ; |
|
~%
113806-05-6 |
| Literature: WO2010/121877 A2, ; Page/Page column 25-26 ; |
|
~%
113806-05-6 |
| Literature: EP2385045 A1, ; |
| Precursor 4 | |
|---|---|
| DownStream 2 | |